What is he best known for?
The fields of study he is best known for:
- Gene
- Internal medicine
- Enzyme
Qingbo Xu spends much of his time researching Immunology, Cell biology, Internal medicine, Pathology and Heat shock protein.
The various areas that Qingbo Xu examines in his Immunology study include Epidemiology, Stem cell and Peripheral blood mononuclear cell.
Kinase is the focus of his Cell biology research.
His Internal medicine research includes themes of Endocrinology and Cardiology.
His work carried out in the field of Pathology brings together such families of science as Progenitor cell, Arteriosclerosis, Sphingomyelin and Coronary artery disease.
His Heat shock protein research integrates issues from Antibody, Autoimmunity, Pathogenesis and Antigen.
His most cited work include:
- Activation of Mitogen-activated Protein Kinase by H2O2: ROLE IN CELL SURVIVAL FOLLOWING OXIDANT INJURY (∗) (1126 citations)
- Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19. (580 citations)
- Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice (544 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Cell biology, Immunology, Stem cell, Internal medicine and Progenitor cell.
His Cell biology research incorporates themes from Endothelial stem cell, Angiogenesis, Vascular smooth muscle and Cellular differentiation.
His work on Heat shock protein expands to the thematically related Immunology.
While the research belongs to areas of Stem cell, Qingbo Xu spends his time largely on the problem of Cell, intersecting his research to questions surrounding Regeneration.
His work deals with themes such as Endocrinology and Cardiology, which intersect with Internal medicine.
His Progenitor cell research includes elements of Myocyte and Adventitia, Pathology.
He most often published in these fields:
- Cell biology (42.98%)
- Immunology (24.56%)
- Stem cell (24.34%)
What were the highlights of his more recent work (between 2016-2021)?
- Cell biology (42.98%)
- Progenitor cell (23.25%)
- Stem cell (24.34%)
In recent papers he was focusing on the following fields of study:
Qingbo Xu focuses on Cell biology, Progenitor cell, Stem cell, Endothelial stem cell and Cell.
His studies deal with areas such as Neointima, Endothelium, Angiogenesis and Vascular smooth muscle as well as Cell biology.
Qingbo Xu has researched Progenitor cell in several fields, including Inflammation, Arteriosclerosis, Neointimal hyperplasia and Transplantation.
His Stem cell research is multidisciplinary, incorporating perspectives in Embryonic stem cell and Cellular differentiation.
The various areas that Qingbo Xu examines in his Endothelial stem cell study include Signal transduction and Immunology.
His Extracellular matrix study which covers Artery that intersects with Pathology.
Between 2016 and 2021, his most popular works were:
- Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19. (580 citations)
- In-Hospital Use of Statins Is Associated with a Reduced Risk of Mortality among Individuals with COVID-19. (150 citations)
- Genetic Lineage Tracing of Nonmyocyte Population by Dual Recombinases. (90 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Enzyme
- Internal medicine
His primary areas of study are Cell biology, Stem cell, Regeneration, Cell and Angiogenesis.
He studies Cell biology, focusing on Signal transduction in particular.
The concepts of his Stem cell study are interwoven with issues in Vascular disease, Endothelium, Neointima and Cellular differentiation.
His Regeneration study combines topics from a wide range of disciplines, such as Cancer research, Homeostasis, Cardiovascular physiology, Myocardial infarction and Coronary circulation.
His Angiogenesis study frequently links to other fields, such as Immunology.
His Immunology study integrates concerns from other disciplines, such as Endothelial stem cell, Clinical uses of mesenchymal stem cells, Vascular smooth muscle, Platelet-derived growth factor receptor and Mesenchymal stem cell.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
